Xantos Biomedicine AG

Bavarian ministry awards grant to expand company's screening technology platform

Published in Managed Care Law Weekly, January 8th, 2006

Xantos Biomedicine AG, a functional biology and drug discovery company, announced that it has been awarded a grant from the Bavarian Ministry of Economic Affairs, Infrastructure, Transport and Technology for the expansion of its technology platform.

The overall aim of the project, which will run for 2 years, is to create applications for the Xantos' service technology platform. Several modules will be implemented and improved to increase the outcome of functional screenings. In addition the project will aim at expanding the use of the OPERA System (Evotec Technologies), a high content screening tool, which is based on confocal microscopy, broadening the range of assays...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Managed Care Law Weekly

Source: Managed Care Law Weekly (2006-01-08)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry